Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium
Provided By GlobeNewswire
Last update: Dec 6, 2024
JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that CFO Raphi Levy will present at the Ladenburg Oncology Innovators & Investors Symposium.
Read more at globenewswire.comNASDAQ:DRTS (6/6/2025, 8:00:01 PM)
3.02
+0.21 (+7.47%)
NASDAQ:DRTSW (6/6/2025, 1:07:54 PM)
0.2398
+0.03 (+14.19%)
Find more stocks in the Stock Screener
